Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

Autolus Therapeutics is working with Cellares to assess automated CAR T manufacturing to support rising demand for its ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United ...

Glioblastoma remains one of the most challenging solid tumors to treat due to its highly immunosuppressive tumor microenvironment.

Explore the best of the West Hall at CES, where the focus shifts from traditional vehicles to cutting-edge auto technology ...

Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the first ...

In modern plants, robots are no longer confined to fenced-off welding cells, they work side by side with people, changing the ...

T he Indian automotive industry has some great hopes from 2026, considering the sales momentum of the past few months after ...

Autolus will evaluate Cellares' fully automated, high-throughput manufacturing platform in preparation for expansion into new indications Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

According to the International Federation of Robotics (IFR), an industry association, there were around 4.7m industrial ...

At CES 2026, Hyundai outlined plans to deploy Boston Dynamics' Atlas humanoid robot in factories across its global network.